US20100047437A1 - Hydrogel balloon prosthesis for nucleus pulposus - Google Patents
Hydrogel balloon prosthesis for nucleus pulposus Download PDFInfo
- Publication number
- US20100047437A1 US20100047437A1 US12/608,565 US60856509A US2010047437A1 US 20100047437 A1 US20100047437 A1 US 20100047437A1 US 60856509 A US60856509 A US 60856509A US 2010047437 A1 US2010047437 A1 US 2010047437A1
- Authority
- US
- United States
- Prior art keywords
- balloon
- prosthesis
- hydrogel
- nucleus pulposus
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
Definitions
- the present invention relates to method and apparatus for replacing or supplementing the natural nucleus pulposus of the intervertebral disc, and more particularly to an expandable or inflatable balloon prosthesis made from a hydrogel for replacing or supplementing the nucleus pulposus.
- Chronic back pain typically lower back pain, caused by injury or age-related degeneration of an intervertebral disc is a condition experienced by many patients.
- Current treatment options for lower back pain range from conservative bed rest to highly invasive surgical procedures, including spinal fusion, discectomy, and total disc replacement.
- the human intervertebral disc is comprised of two major structures, an inner gelatinous structure (i.e., the nucleus pulposus) and an outer tendinous structure (i.e., the annulus fibrosus). Degeneration of the nucleus can lead to disc degradation and loss of function. Thus, another surgical option for the relief of lower back pain is replacement of the nucleus while leaving the annulus intact.
- a biocompatible material which may be a liquid, a gel, or the like, can relieve pain, restore healthy physiologic function to the disc, and/or prevent additional wear on the annulus.
- a need has continued to exist for a method and apparatus that make it possible to confine an injected or otherwise introduced material, e.g., a gel or liquid, within the nucleus pulposus region of the intervertebral disk.
- an injected or otherwise introduced material e.g., a gel or liquid
- the invention of this application addresses the many problems relating to confinement of gels, liquids, or the like, introduced into the region of the nucleus pulposus.
- a hollow expandable or inflatable vessel made from a hydrogel is inserted into the nucleus pulposus region of an intervertebral disk, optionally after a portion or the entirety of the natural nucleus pulposus has been removed, and the vessel is then expanded by introducing a gel, liquid, or the like, to provide an intradiscal structure that supplements or replaces the natural nucleus pulposus.
- one aspect of the invention is to provide a structure for replacing or supplementing the natural nucleus pulposus of an intervertebral disc.
- a further aspect is to provide a structure that can confine an injected liquid but which can also expand and deform to completely fill a cavity within an intervertebral disk.
- a further aspect is to provide an expandable structure, such as a balloon, that is made of a biocompatible polymer.
- a further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol) or a mixture of associating polymers containing poly(vinyl alcohol).
- a further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol), or a mixture of associating polymers containing poly(vinyl alcohol), that can be formed by a process of dip-coating a mandrel.
- a further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol) or a mixture of associating polymers containing poly(vinyl alcohol).
- a further aspect is to provide a method for replacing or supplementing a nucleus pulposus of an intervertebral disk by inserting a flexible-walled container or balloon made from a hydrogel into the nucleus pulposus region of the intervertebral disk by a minimally invasive surgical procedure and subsequently expanding the container or balloon by introducing a material having properties appropriate for replacing or supplementing a natural nucleus pulposus.
- FIG. 1 shows an expandable hollow prosthesis of one embodiment of the invention.
- FIG. 2 shows a cross-section of the prosthesis of FIG. 1 taken along the line 2 - 2 in FIG. 1 .
- FIG. 3 shows a plan view of another embodiment of the prosthesis of one embodiment of the invention wherein the expandable container is molded generally in the shape of a natural nucleus pulposus.
- FIG. 4 shows an elevation view of the prosthesis of FIG. 3 in the direction indicated by the arrows 4 - 4 in FIG. 3 .
- FIG. 5 shows a cross-section of the prosthesis of FIGS. 3 and 4 taken along the line 5 - 5 in FIG. 3 .
- FIG. 6 shows a schematic cross-section of a spinal motion segment showing a tubular insertion instrument with a prosthesis of one embodiment of the invention in collapsed form mounted on a filling tube within the insertion tube.
- FIG. 7 shows the prosthesis in collapsed form inserted into the nucleus pulposus cavity of an intervertebral disk, optionally after removal of all or part of the natural nucleus pulposus.
- FIG. 8 shows the prosthesis being expanded within the intervertebral disk by insertion of a filler material through the filling tube.
- FIG. 9 shows the prosthesis fully expanded within the intervertebral disk and sealed.
- the nucleus pulposus may experience certain pathological conditions. Normal aging causes the water content of the nucleus to decrease, resulting in a reduced ability to support the loads imposed on it and a reduction in the height of the intervertebral disc. As a result of degeneration of the annulus fibrosus, a portion of the nucleus may become herniated through cracks in the annulus and cause pain by impinging upon the spinal nerve roots. Accordingly, at least the herniated portion of the nucleus may be removed surgically to alleviate the pain. In some conditions the entire nucleus pulposus may be surgically removed.
- Such surgery may be effective to relieve pain, but may leave the intervertebral disc without an adequately functioning nucleus pulposus, thus leaving the possibility of further degeneration of the intervertebral disc. Accordingly, it may be desirable to supplement a degenerated nucleus pulposus or to replace an excised portion or even the entire nucleus in order to restore at least some of the functionality provided by the intact, undegenerated nucleus pulposus.
- a prosthesis for replacing or supplementing the nucleus pulposus of an intervertebral disk comprises an expandable balloon made from a hydrogel material, whereby the wall of the balloon is comprised of a hydrogel.
- the wall of the balloon may have a thickness from 0.01 to 2.00, more preferably, from 0.02 mm to 1.00 mm.
- the balloon may have a tensile modulus of 0.02 MPa to 0.8 MPa at 30% strain.
- the wall of the balloon may have a thickness from 0.01 to 2.00, more preferably, from 0.02 mm to 1.00 mm, and the balloon may have a tensile modulus of 0.02 MPa to 0.8 MPa at 30% strain.
- the balloon is capable of having a volume expansion of 3 to 5 times the original volume before bursting.
- the balloon is collapsible, e.g., by folding, rolling, or the like, to a relatively small size preferably for insertion into the central cavity of the intervertebral disk through a minimally invasive opening, optionally after a portion or substantially all of the nucleus pulposus has been removed.
- the wall of the balloon is made as a flexible membrane having a thickness and strength sufficient to support the internal pressure exerted by a filling material.
- the balloon prosthesis is collapsed to a relatively small volume and inserted into the central cavity of the intervertebral disc, e.g., through a cannula inserted through the annulus fibrosus or through a channel made in the body of an adjacent vertebra.
- the balloon prosthesis is typically inserted by a conventional minimally invasive surgical technique.
- the balloon is expanded by insertion of a relatively incompressible material into its interior in order to supplement or replace the nucleus pulposus.
- the balloon may deform as it is expanded to substantially completely fill the available volume within the space left by the degeneration and/or surgical removal of the body of the nucleus pulposus.
- the balloon may be originally made in a shape to conform to a cavity left by such degeneration or surgical removal.
- the filling of the balloon is preferably continued until it has substantially filled the available volume within the nucleus pulposus cavity and has been pressurized to substantially restore the natural pressure within the nucleus pulposus region of the intervertebral disk.
- the balloon is expanded within the nucleus pulposus region to the extent that the natural disk height for a given individual patient is restored.
- the hydrogel material that forms the wall of the balloon prosthesis may include any biocompatible hydrogel that has sufficient strength to confine the filling material under pressures existing within the region of the nucleus pulposus. Suitable hydrogels may be selected from among the many known hydrogels, including those disclosed, e.g., in U.S. Pat. No. 5,047,055, to Bao et al., the entire disclosure of which is incorporated herein by reference.
- a preferred material for forming the balloon prosthesis is a hydrogel based on poly(vinyl alcohol) (PVA) that can be formed by repeated freeze-thaw cycles of an aqueous solution of PVA as described, e.g., in U.S. Pat. Nos.
- cryogels are solid materials having elastomeric properties containing a large proportion, e.g., over 80%, of water, which are produced when solutions of relatively high molecular weight PVA of a high degree of hydrolysis are subjected to repeated freeze-thaw cycles.
- Such cryogels are tough, elastomeric, resilient, substantially insoluble in water below about 50° C., and nontoxic.
- a particularly preferred material is a cryogel formed by repeated freeze-thaw cycles of an aqueous solution of a mixture of PVA with another associating polymer such as poly(vinyl pyrrolidone) (PVP).
- the preferred embodiments of the cryogel may comprise a blend of PVA and 0.1% to 50%, more preferably 1% to 5% of a second polymer, preferably PVP or copolymers of PVP and poly(methyl methacrylate), poly(acrylamide), poly(acrylic acid), poly(acrylonitrile), or poly(ethylene glycol).
- the polymer component of such hydrogels may comprise from about 0.5% by weight to about 25% by weight of PVP, the remainder being PVA.
- the polymer component may incorporate from about 0.5% to about 5% by weight of PVP, for example, about 2.5% of PVP, the remainder being PVA.
- PVP polymer component
- Such hydrogels are disclosed in U.S. patent application Ser. No. 10/111,782, to Marcolongo et al. (European Patent No. EP 1 229873), the entire disclosure of which is incorporated herein by reference.
- the expandable balloon prosthesis may be made in any shape that is suitable for filling the cavity of the nucleus pulposus of an intervertebral disk.
- FIG. 1 shows a prosthesis 100 having a generally ellipsoidal chamber 102 and a filling tube 104 through which the prosthesis is filled with a relatively incompressible material after implantation.
- FIG. 2 shows a cross-section of the prosthesis of FIG. 1 along the line 2 - 2 in FIG. 1 , showing the thin membrane wall 106 surrounding an interior volume 108 .
- Such a prosthesis may be prepared from a hydrogel that has sufficient elasticity to allow the balloon to deform under the internal pressure of the filling material to substantially fill void space within the nucleus pulposus region of the intervertebral disc.
- FIG. 3 shows a plan view of another prosthesis 200 wherein the inflatable chamber 202 of the prosthesis 200 has been molded in the general shape of the natural nucleus pulposus.
- the prosthesis 200 is also provided with a filling tube 204 .
- FIG. 4 shows an elevational view of the prosthesis of FIG. 3 in the direction indicated by the arrows 4 - 4 in FIG. 3 .
- FIG. 5 shows a cross-sectional view of the prosthesis 200 of FIG. 3 taken along the line 5 - 5 in FIG. 3 .
- FIG. 5 shows the membrane wall 206 and internal volume 208 of the prosthesis.
- the balloon prosthesis may be manufactured by any conventional process for forming a hollow container having a flexible membrane wall.
- the container may be formed by conventional methods for forming objects from synthetic polymers such as blow molding, injection molding, rotational molding, extrusion, and the like.
- the container may also be formed by adhesive assembly of thin, flexible sheets of a hydrogel. It is preferred to form the balloon by dip-coating a mandrel with a dispersion or solution of a polymer capable of forming a cryogel in a suitable liquid vehicle, e.g., water, subsequently solidifying the coating on the mandrel by drying, chilling, or the like, and then subjecting the balloon to repeated freeze-thaw cycles to form a cryogel balloon.
- a suitable liquid vehicle e.g., water
- a particularly preferred method of forming the hydrogel balloon is by dip coating a mandrel with an aqueous dispersion of a PYA or PVA-PVP blend followed by rapid chilling to a temperature that is effective to cause the coated layer to form a gel.
- a temperature will typically be below ⁇ 20° C.
- Rapid chilling of the coating of polymer dispersion on the mandrel can be accomplished by dipping the coated mandrel into liquid nitrogen having a temperature of about ⁇ 198.5° C. (77.35 K).
- the hydrogel coating so formed may then be further processed by several cycles of freezing and thawing, as is conventional for such hydrogels.
- the balloon is then removed from the mandrel and is ready for use in the process of the invention.
- FIGS. 6-9 The implantation and filling of a hydrogel balloon prosthesis is schematically illustrated in FIGS. 6-9 .
- the figures illustrate schematically a superior or cranial view of a typical lumbar vertebra 300 with intervertebral disc 302 having an annulus fibrosus 304 and a central volume 306 representing a void space due to degeneration of the nucleus pulposus or removal thereof by a surgical procedure.
- An insertion cannula or trocar 308 is inserted through the annulus fibrosus 304 and into the central volume 306 .
- a balloon prosthesis 100 is collapsed, as by folding or rolling, attached to a carrier tube 310 , and introduced into the insertion tube 308 .
- FIG. 6 shows the balloon prosthesis 100 within the insertion tube 308 , just before implantation.
- FIG. 7 shows the initial stage of the implantation wherein the balloon prosthesis 100 has been positioned within the central volume 306 of the annulus fibrosus 304 by advancing the carrier tube 310 through the insertion tube 308 .
- FIG. 8 shows an intermediate stage in the implantation wherein the balloon prosthesis 100 has been partially inflated with material introduced through the carrier tube 310 .
- FIG. 9 shows the final stage of the implantation wherein the balloon prosthesis 100 has been completely inflated and substantially fills the central volume 306 of the annulus fibrosus 304 .
- the fill tube is sealed by any conventional procedure, e.g., by insertion of a plug, tying off, etc., the carrier tube 310 is detached and withdrawn, and the insertion tube is withdrawn from the annulus fibrosus.
- the balloon prosthesis 100 may be inflated with any material that will remain confined by the hydrogel membrane of the balloon prosthesis and will provide mechanical properties similar to those of the natural nucleus pulposus.
- the balloon prosthesis may be filled with a curable material injected in a liquid or plastic state that will cure after injection to an elastic or viscoelastic material preferably having properties similar to those of the natural nucleus pulposus.
- a preferred material for filling the balloon prosthesis of the invention is a hydrogel that can be injected in a liquid or soft injectable state and that will preferably provide the prosthesis with mechanical properties similar to those of the natural nucleus pulposus.
- a particularly preferred material is a thermogelling composition that can be injected in a liquid form at a temperature approximating room temperature and that will then become converted to a gel form when it is heated to normal body temperature.
- Such compositions are known, and include, for example, thermogelling hydrogel materials based on poly(N-isopropylacrylamide) (PNIPAAm) or a copolymer or blend of PNIPAAm, as disclosed in U.S. Published Patent Application No. 2004/0220296 (application Ser. No.
- thermogelling composition may be injected into the balloon at a relatively low temperature at which it remains a flowable liquid, e.g., about 20° C. to about 27° C.
- the thermogelling hydrogel is warmed, typically merely by conduction of heat from its surroundings, to body temperature of about 37° C. and forms a solid hydrogel.
- the solid hydrogel so formed will not flow out through the neck of the balloon; accordingly no special sealing of the input stem or neck of the balloon is needed in this embodiment.
- thermogelling hydrogels based on PNIPAAm are disclosed in U.S. Published Patent Application No. 2004/0220296, and include those prepared from blends of aqueous solutions of PNIPAAm with aqueous solutions of poly(vinyl alcohol) (PVA), and aqueous solutions of poly(ethylene glycols) (PEGs) of various molecular weights. Also disclosed are thermogelling hydrogels prepared from aqueous solutions of PNIPAAm-grafted PEG polymers and aqueous solutions of PEG-PNIPAAm-PEG triblock polymers. Such thermogelling hydrogels, and the like, are preferred materials for filling the balloon prosthesis.
- the balloon prosthesis can be filled with a conventional biocompatible liquid.
- the neck of the balloon is sealed by conventional procedures, e.g., sealing with a plug, sealing with an adhesive, heat-sealing, stitching, or the like.
- the balloon prosthesis may also be filled or packed with a solid hydrogel in the form of beads or a string that will serve to provide the prosthesis with the requisite mechanical properties.
- a solid hydrogel in the form of beads or a string that will serve to provide the prosthesis with the requisite mechanical properties.
- the neck or stem of the balloon may be sealed as indicated above. If the size, shape, stiffness, or other properties of the inserted solid hydrogel material are such that it will not be extruded through the neck of the balloon, special sealing of the stem need not be performed.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Colloid Chemistry (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
A prosthesis for replacing or supplementing a nucleus pulposus of an intervertebral disk is an expandable container having flexible walls, the container being adapted to be inserted into a central cavity of an intervertebral disk through a narrow cannula, and the flexible walls are made from a biocompatible hydrogel. A preferred hydrogel is a cryogel formed from an aqueous solution of poly(vinyl alcohol) and poly(vinyl pyrrolidone). The prosthesis may be prepared by dip-coating a mandrel with an aqueous solution of a hydrogel-forming polymer or mixture of such polymers, gelling the coated solution by chilling, and subjecting the gelled coating to a series of repeated freeze-thaw treatments. In use, the prosthesis is inserted into a central cavity of an intervertebral disk and filled with biocompatible material, e.g., a biocompatible liquid, a biocompatible polymer, and a biocompatible hydrogel, particularly a thermogelling hydrogel.
Description
- This application is a division of U.S. application Ser. No. 11/510,747, filed on Aug. 25, 2006, which claimed priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 60/711,430, filed Aug. 26, 2005, all of which are incorporated by reference herein in their entirety.
- The present invention relates to method and apparatus for replacing or supplementing the natural nucleus pulposus of the intervertebral disc, and more particularly to an expandable or inflatable balloon prosthesis made from a hydrogel for replacing or supplementing the nucleus pulposus.
- Chronic back pain, typically lower back pain, caused by injury or age-related degeneration of an intervertebral disc is a condition experienced by many patients. Current treatment options for lower back pain range from conservative bed rest to highly invasive surgical procedures, including spinal fusion, discectomy, and total disc replacement.
- The human intervertebral disc is comprised of two major structures, an inner gelatinous structure (i.e., the nucleus pulposus) and an outer tendinous structure (i.e., the annulus fibrosus). Degeneration of the nucleus can lead to disc degradation and loss of function. Thus, another surgical option for the relief of lower back pain is replacement of the nucleus while leaving the annulus intact.
- Replacement or supplementation of the nucleus pulposus, e.g., by introducing a biocompatible material, which may be a liquid, a gel, or the like, can relieve pain, restore healthy physiologic function to the disc, and/or prevent additional wear on the annulus.
- Accordingly, a need has continued to exist for a method and apparatus that make it possible to confine an injected or otherwise introduced material, e.g., a gel or liquid, within the nucleus pulposus region of the intervertebral disk.
- The invention of this application addresses the many problems relating to confinement of gels, liquids, or the like, introduced into the region of the nucleus pulposus.
- According to the invention, a hollow expandable or inflatable vessel made from a hydrogel is inserted into the nucleus pulposus region of an intervertebral disk, optionally after a portion or the entirety of the natural nucleus pulposus has been removed, and the vessel is then expanded by introducing a gel, liquid, or the like, to provide an intradiscal structure that supplements or replaces the natural nucleus pulposus.
- Accordingly, one aspect of the invention is to provide a structure for replacing or supplementing the natural nucleus pulposus of an intervertebral disc.
- A further aspect is to provide a structure that can confine an injected liquid but which can also expand and deform to completely fill a cavity within an intervertebral disk.
- A further aspect is to provide an expandable structure, such as a balloon, that is made of a biocompatible polymer.
- A further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol) or a mixture of associating polymers containing poly(vinyl alcohol).
- A further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol), or a mixture of associating polymers containing poly(vinyl alcohol), that can be formed by a process of dip-coating a mandrel.
- A further aspect is to provide an expandable structure, such as a balloon, that is made of a hydrogel containing poly(vinyl alcohol) or a mixture of associating polymers containing poly(vinyl alcohol).
- A further aspect is to provide a method for replacing or supplementing a nucleus pulposus of an intervertebral disk by inserting a flexible-walled container or balloon made from a hydrogel into the nucleus pulposus region of the intervertebral disk by a minimally invasive surgical procedure and subsequently expanding the container or balloon by introducing a material having properties appropriate for replacing or supplementing a natural nucleus pulposus. Further aspects of the invention will be apparent from the description of the invention which follows.
-
FIG. 1 shows an expandable hollow prosthesis of one embodiment of the invention. -
FIG. 2 shows a cross-section of the prosthesis ofFIG. 1 taken along the line 2-2 inFIG. 1 . -
FIG. 3 shows a plan view of another embodiment of the prosthesis of one embodiment of the invention wherein the expandable container is molded generally in the shape of a natural nucleus pulposus. -
FIG. 4 shows an elevation view of the prosthesis ofFIG. 3 in the direction indicated by the arrows 4-4 inFIG. 3 . -
FIG. 5 shows a cross-section of the prosthesis ofFIGS. 3 and 4 taken along the line 5-5 inFIG. 3 . -
FIG. 6 shows a schematic cross-section of a spinal motion segment showing a tubular insertion instrument with a prosthesis of one embodiment of the invention in collapsed form mounted on a filling tube within the insertion tube. -
FIG. 7 shows the prosthesis in collapsed form inserted into the nucleus pulposus cavity of an intervertebral disk, optionally after removal of all or part of the natural nucleus pulposus. -
FIG. 8 shows the prosthesis being expanded within the intervertebral disk by insertion of a filler material through the filling tube. -
FIG. 9 shows the prosthesis fully expanded within the intervertebral disk and sealed. - As the intervertebral disc ages, the nucleus pulposus may experience certain pathological conditions. Normal aging causes the water content of the nucleus to decrease, resulting in a reduced ability to support the loads imposed on it and a reduction in the height of the intervertebral disc. As a result of degeneration of the annulus fibrosus, a portion of the nucleus may become herniated through cracks in the annulus and cause pain by impinging upon the spinal nerve roots. Accordingly, at least the herniated portion of the nucleus may be removed surgically to alleviate the pain. In some conditions the entire nucleus pulposus may be surgically removed. Such surgery may be effective to relieve pain, but may leave the intervertebral disc without an adequately functioning nucleus pulposus, thus leaving the possibility of further degeneration of the intervertebral disc. Accordingly, it may be desirable to supplement a degenerated nucleus pulposus or to replace an excised portion or even the entire nucleus in order to restore at least some of the functionality provided by the intact, undegenerated nucleus pulposus.
- According to one embodiment of the invention, a prosthesis for replacing or supplementing the nucleus pulposus of an intervertebral disk comprises an expandable balloon made from a hydrogel material, whereby the wall of the balloon is comprised of a hydrogel. In certain embodiments, the wall of the balloon may have a thickness from 0.01 to 2.00, more preferably, from 0.02 mm to 1.00 mm. In certain other embodiments, the balloon may have a tensile modulus of 0.02 MPa to 0.8 MPa at 30% strain. In certain other embodiments, the wall of the balloon may have a thickness from 0.01 to 2.00, more preferably, from 0.02 mm to 1.00 mm, and the balloon may have a tensile modulus of 0.02 MPa to 0.8 MPa at 30% strain. Preferably, the balloon is capable of having a volume expansion of 3 to 5 times the original volume before bursting.
- The balloon is collapsible, e.g., by folding, rolling, or the like, to a relatively small size preferably for insertion into the central cavity of the intervertebral disk through a minimally invasive opening, optionally after a portion or substantially all of the nucleus pulposus has been removed. To this end, the wall of the balloon is made as a flexible membrane having a thickness and strength sufficient to support the internal pressure exerted by a filling material. In use, the balloon prosthesis is collapsed to a relatively small volume and inserted into the central cavity of the intervertebral disc, e.g., through a cannula inserted through the annulus fibrosus or through a channel made in the body of an adjacent vertebra. Thus, the balloon prosthesis is typically inserted by a conventional minimally invasive surgical technique.
- Once the balloon has been implanted in the nucleus pulposus cavity, it is expanded by insertion of a relatively incompressible material into its interior in order to supplement or replace the nucleus pulposus. The balloon may deform as it is expanded to substantially completely fill the available volume within the space left by the degeneration and/or surgical removal of the body of the nucleus pulposus. Alternatively, the balloon may be originally made in a shape to conform to a cavity left by such degeneration or surgical removal. The filling of the balloon is preferably continued until it has substantially filled the available volume within the nucleus pulposus cavity and has been pressurized to substantially restore the natural pressure within the nucleus pulposus region of the intervertebral disk. Preferably the balloon is expanded within the nucleus pulposus region to the extent that the natural disk height for a given individual patient is restored.
- The hydrogel material that forms the wall of the balloon prosthesis may include any biocompatible hydrogel that has sufficient strength to confine the filling material under pressures existing within the region of the nucleus pulposus. Suitable hydrogels may be selected from among the many known hydrogels, including those disclosed, e.g., in U.S. Pat. No. 5,047,055, to Bao et al., the entire disclosure of which is incorporated herein by reference. A preferred material for forming the balloon prosthesis is a hydrogel based on poly(vinyl alcohol) (PVA) that can be formed by repeated freeze-thaw cycles of an aqueous solution of PVA as described, e.g., in U.S. Pat. Nos. 5,260,066 and 5,288,503, to Wood et al., and U.S. Pat. No. 5,981,826, to Ku et al., the entire disclosures of which are incorporated herein by reference. Such materials, generally referred to as cryogels, are solid materials having elastomeric properties containing a large proportion, e.g., over 80%, of water, which are produced when solutions of relatively high molecular weight PVA of a high degree of hydrolysis are subjected to repeated freeze-thaw cycles. Such cryogels are tough, elastomeric, resilient, substantially insoluble in water below about 50° C., and nontoxic. A particularly preferred material is a cryogel formed by repeated freeze-thaw cycles of an aqueous solution of a mixture of PVA with another associating polymer such as poly(vinyl pyrrolidone) (PVP). Accordingly, the preferred embodiments of the cryogel may comprise a blend of PVA and 0.1% to 50%, more preferably 1% to 5% of a second polymer, preferably PVP or copolymers of PVP and poly(methyl methacrylate), poly(acrylamide), poly(acrylic acid), poly(acrylonitrile), or poly(ethylene glycol). The polymer component of such hydrogels may comprise from about 0.5% by weight to about 25% by weight of PVP, the remainder being PVA. In preferred hydrogels of this type the polymer component may incorporate from about 0.5% to about 5% by weight of PVP, for example, about 2.5% of PVP, the remainder being PVA. Such hydrogels are disclosed in U.S. patent application Ser. No. 10/111,782, to Marcolongo et al. (European Patent No. EP 1 229873), the entire disclosure of which is incorporated herein by reference.
- The expandable balloon prosthesis may be made in any shape that is suitable for filling the cavity of the nucleus pulposus of an intervertebral disk.
FIG. 1 shows aprosthesis 100 having a generallyellipsoidal chamber 102 and a fillingtube 104 through which the prosthesis is filled with a relatively incompressible material after implantation.FIG. 2 shows a cross-section of the prosthesis ofFIG. 1 along the line 2-2 inFIG. 1 , showing thethin membrane wall 106 surrounding aninterior volume 108. Such a prosthesis may be prepared from a hydrogel that has sufficient elasticity to allow the balloon to deform under the internal pressure of the filling material to substantially fill void space within the nucleus pulposus region of the intervertebral disc. -
FIG. 3 shows a plan view of anotherprosthesis 200 wherein theinflatable chamber 202 of theprosthesis 200 has been molded in the general shape of the natural nucleus pulposus. Theprosthesis 200 is also provided with a fillingtube 204.FIG. 4 shows an elevational view of the prosthesis ofFIG. 3 in the direction indicated by the arrows 4-4 inFIG. 3 .FIG. 5 shows a cross-sectional view of theprosthesis 200 ofFIG. 3 taken along the line 5-5 inFIG. 3 .FIG. 5 shows themembrane wall 206 andinternal volume 208 of the prosthesis. - The balloon prosthesis may be manufactured by any conventional process for forming a hollow container having a flexible membrane wall. The container may be formed by conventional methods for forming objects from synthetic polymers such as blow molding, injection molding, rotational molding, extrusion, and the like. The container may also be formed by adhesive assembly of thin, flexible sheets of a hydrogel. It is preferred to form the balloon by dip-coating a mandrel with a dispersion or solution of a polymer capable of forming a cryogel in a suitable liquid vehicle, e.g., water, subsequently solidifying the coating on the mandrel by drying, chilling, or the like, and then subjecting the balloon to repeated freeze-thaw cycles to form a cryogel balloon. A particularly preferred method of forming the hydrogel balloon is by dip coating a mandrel with an aqueous dispersion of a PYA or PVA-PVP blend followed by rapid chilling to a temperature that is effective to cause the coated layer to form a gel. Such a temperature will typically be below −20° C. Rapid chilling of the coating of polymer dispersion on the mandrel can be accomplished by dipping the coated mandrel into liquid nitrogen having a temperature of about −198.5° C. (77.35 K). The hydrogel coating so formed may then be further processed by several cycles of freezing and thawing, as is conventional for such hydrogels. The balloon is then removed from the mandrel and is ready for use in the process of the invention.
- The implantation and filling of a hydrogel balloon prosthesis is schematically illustrated in
FIGS. 6-9 . The figures illustrate schematically a superior or cranial view of a typicallumbar vertebra 300 withintervertebral disc 302 having anannulus fibrosus 304 and acentral volume 306 representing a void space due to degeneration of the nucleus pulposus or removal thereof by a surgical procedure. An insertion cannula ortrocar 308 is inserted through theannulus fibrosus 304 and into thecentral volume 306. Aballoon prosthesis 100 is collapsed, as by folding or rolling, attached to acarrier tube 310, and introduced into theinsertion tube 308.FIG. 6 shows theballoon prosthesis 100 within theinsertion tube 308, just before implantation.FIG. 7 shows the initial stage of the implantation wherein theballoon prosthesis 100 has been positioned within thecentral volume 306 of theannulus fibrosus 304 by advancing thecarrier tube 310 through theinsertion tube 308.FIG. 8 shows an intermediate stage in the implantation wherein theballoon prosthesis 100 has been partially inflated with material introduced through thecarrier tube 310.FIG. 9 shows the final stage of the implantation wherein theballoon prosthesis 100 has been completely inflated and substantially fills thecentral volume 306 of theannulus fibrosus 304. After the inflation of theballoon prosthesis 100 is complete, the fill tube is sealed by any conventional procedure, e.g., by insertion of a plug, tying off, etc., thecarrier tube 310 is detached and withdrawn, and the insertion tube is withdrawn from the annulus fibrosus. - The
balloon prosthesis 100 may be inflated with any material that will remain confined by the hydrogel membrane of the balloon prosthesis and will provide mechanical properties similar to those of the natural nucleus pulposus. Thus, the balloon prosthesis may be filled with a curable material injected in a liquid or plastic state that will cure after injection to an elastic or viscoelastic material preferably having properties similar to those of the natural nucleus pulposus. - A preferred material for filling the balloon prosthesis of the invention is a hydrogel that can be injected in a liquid or soft injectable state and that will preferably provide the prosthesis with mechanical properties similar to those of the natural nucleus pulposus. A particularly preferred material is a thermogelling composition that can be injected in a liquid form at a temperature approximating room temperature and that will then become converted to a gel form when it is heated to normal body temperature. Such compositions are known, and include, for example, thermogelling hydrogel materials based on poly(N-isopropylacrylamide) (PNIPAAm) or a copolymer or blend of PNIPAAm, as disclosed in U.S. Published Patent Application No. 2004/0220296 (application Ser. No. 10/837,082), by Lowman et al., the entire disclosure of which is incorporated herein by reference. After the balloon prosthesis has been implanted, such a thermogelling composition may be injected into the balloon at a relatively low temperature at which it remains a flowable liquid, e.g., about 20° C. to about 27° C. After injection, the thermogelling hydrogel is warmed, typically merely by conduction of heat from its surroundings, to body temperature of about 37° C. and forms a solid hydrogel. The solid hydrogel so formed will not flow out through the neck of the balloon; accordingly no special sealing of the input stem or neck of the balloon is needed in this embodiment.
- Typical thermogelling hydrogels based on PNIPAAm are disclosed in U.S. Published Patent Application No. 2004/0220296, and include those prepared from blends of aqueous solutions of PNIPAAm with aqueous solutions of poly(vinyl alcohol) (PVA), and aqueous solutions of poly(ethylene glycols) (PEGs) of various molecular weights. Also disclosed are thermogelling hydrogels prepared from aqueous solutions of PNIPAAm-grafted PEG polymers and aqueous solutions of PEG-PNIPAAm-PEG triblock polymers. Such thermogelling hydrogels, and the like, are preferred materials for filling the balloon prosthesis.
- Alternatively, the balloon prosthesis can be filled with a conventional biocompatible liquid. After the injection of such a liquid, the neck of the balloon is sealed by conventional procedures, e.g., sealing with a plug, sealing with an adhesive, heat-sealing, stitching, or the like.
- The balloon prosthesis may also be filled or packed with a solid hydrogel in the form of beads or a string that will serve to provide the prosthesis with the requisite mechanical properties. Depending on the cross-section of the inserted material, the neck or stem of the balloon may be sealed as indicated above. If the size, shape, stiffness, or other properties of the inserted solid hydrogel material are such that it will not be extruded through the neck of the balloon, special sealing of the stem need not be performed.
- The invention having now been described in terms of certain preferred embodiments, it will be understood that modifications and changes can be made thereto without departing from the spirit and character thereof.
Claims (7)
1. A method of forming an expandable cryogel balloon having flexible walls defining an inner cavity, comprising the steps of:
(i) dip-coating a mandrel with an aqueous solution comprising poly(vinyl alcohol) to form a coated solution,
(ii) chilling the dip-coated mandrel to a temperature sufficient to cause the aqueous solution to form a gel;
(iii) subjecting the coating to at least two cycles of freezing and thawing to form the cryogel balloon; and
(iv) removing the balloon from the mandrel.
2. The method of claim 1 , wherein the aqueous solution further comprises poly(vinyl pyrrolidone).
3. The method of claim 1 , wherein the chilling step is performed at a temperature of less than −20° C.
4. The method of claim 1 , wherein the chilling step is performed by dipping the coated mandrel into liquid nitrogen.
5. The method of claim 1 , wherein the flexible walls have a thickness from about 0.02 mm to about 1.00 mm.
6. The method of claim 1 , wherein the balloon has a filling tube passing through the flexible walls and in communication with the inner cavity so that the balloon is fillable.
7. The method of claim 1 , wherein the balloon has a shape generally conforming to the shape of a natural nucleus pulposus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/608,565 US20100047437A1 (en) | 2005-08-26 | 2009-10-29 | Hydrogel balloon prosthesis for nucleus pulposus |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71143005P | 2005-08-26 | 2005-08-26 | |
US11/510,747 US8287595B2 (en) | 2005-08-26 | 2006-08-25 | Hydrogel balloon prosthesis for nucleus pulposus |
US12/608,565 US20100047437A1 (en) | 2005-08-26 | 2009-10-29 | Hydrogel balloon prosthesis for nucleus pulposus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/510,747 Division US8287595B2 (en) | 2005-08-26 | 2006-08-25 | Hydrogel balloon prosthesis for nucleus pulposus |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100047437A1 true US20100047437A1 (en) | 2010-02-25 |
Family
ID=37772444
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/510,747 Active 2029-05-28 US8287595B2 (en) | 2005-08-26 | 2006-08-25 | Hydrogel balloon prosthesis for nucleus pulposus |
US12/608,565 Abandoned US20100047437A1 (en) | 2005-08-26 | 2009-10-29 | Hydrogel balloon prosthesis for nucleus pulposus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/510,747 Active 2029-05-28 US8287595B2 (en) | 2005-08-26 | 2006-08-25 | Hydrogel balloon prosthesis for nucleus pulposus |
Country Status (15)
Country | Link |
---|---|
US (2) | US8287595B2 (en) |
EP (1) | EP1917050B1 (en) |
JP (1) | JP4896135B2 (en) |
KR (1) | KR20080036217A (en) |
CN (1) | CN101365500B (en) |
AT (1) | ATE464076T1 (en) |
AU (1) | AU2006282883A1 (en) |
BR (1) | BRPI0615391A2 (en) |
CA (1) | CA2620239A1 (en) |
DE (1) | DE602006013649D1 (en) |
ES (1) | ES2340526T3 (en) |
NZ (1) | NZ566184A (en) |
PL (1) | PL1917050T3 (en) |
WO (1) | WO2007025164A2 (en) |
ZA (1) | ZA200802596B (en) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030008396A1 (en) * | 1999-03-17 | 2003-01-09 | Ku David N. | Poly(vinyl alcohol) hydrogel |
CA2591678C (en) | 1999-03-07 | 2008-05-20 | Active Implants Corporation | Method and apparatus for computerized surgery |
JP2004507318A (en) * | 2000-08-30 | 2004-03-11 | エスディージーアイ・ホールディングス・インコーポレーテッド | Disc nucleus pulposus implant and method |
AU2003290627B2 (en) * | 2002-11-05 | 2009-03-19 | Spineology, Inc. | A semi-biological intervertebral disc replacement system |
AU2005212339B2 (en) | 2004-02-06 | 2010-11-25 | Georgia Tech Research Corporation | Load bearing biocompatible device |
US8002830B2 (en) * | 2004-02-06 | 2011-08-23 | Georgia Tech Research Corporation | Surface directed cellular attachment |
US20050278025A1 (en) * | 2004-06-10 | 2005-12-15 | Salumedica Llc | Meniscus prosthesis |
US20070049849A1 (en) * | 2005-05-24 | 2007-03-01 | Schwardt Jeffrey D | Bone probe apparatus and method of use |
US20070042326A1 (en) * | 2005-06-01 | 2007-02-22 | Osseous Technologies Of America | Collagen antral membrane expander |
BRPI0615391A2 (en) * | 2005-08-26 | 2011-05-17 | Synthes Gmbh | prosthesis to replace or supplement a pulpous nucleus of an intervertebral disc |
US11896505B2 (en) * | 2005-10-31 | 2024-02-13 | Scott M. Epstein | Methods for making and using a structural hydrogel polymer device |
US8577469B2 (en) | 2006-07-12 | 2013-11-05 | Rainbow Medical Ltd. | Iontophoretic and electroosmotic disc treatment |
US7758649B2 (en) * | 2006-08-04 | 2010-07-20 | Integrity Intellect Inc. | Reversibly deformable implant |
US8029569B2 (en) * | 2006-11-20 | 2011-10-04 | International Spinal Innovations, Llc | Implantable spinal disk |
US20080161929A1 (en) | 2006-12-29 | 2008-07-03 | Mccormack Bruce | Cervical distraction device |
WO2009089367A2 (en) | 2008-01-09 | 2009-07-16 | Providence Medical Technology, Inc. | Methods and apparatus for accessing and treating the facet joint |
JP2011516122A (en) * | 2008-03-28 | 2011-05-26 | スパイノロジー インコーポレイテッド | Spinous process fusion method and device |
US7976578B2 (en) * | 2008-06-04 | 2011-07-12 | James Marvel | Buffer for a human joint and method of arthroscopically inserting |
US8361152B2 (en) | 2008-06-06 | 2013-01-29 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US8267966B2 (en) | 2008-06-06 | 2012-09-18 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
WO2010030994A2 (en) | 2008-06-06 | 2010-03-18 | Providence Medical Technology, Inc. | Cervical distraction/implant delivery device |
US11224521B2 (en) | 2008-06-06 | 2022-01-18 | Providence Medical Technology, Inc. | Cervical distraction/implant delivery device |
EP2328492B1 (en) | 2008-06-06 | 2018-03-28 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US9333086B2 (en) | 2008-06-06 | 2016-05-10 | Providence Medical Technology, Inc. | Spinal facet cage implant |
US9381049B2 (en) | 2008-06-06 | 2016-07-05 | Providence Medical Technology, Inc. | Composite spinal facet implant with textured surfaces |
AU2014240268B2 (en) * | 2008-09-05 | 2016-10-13 | Cardiopolymers, Inc. | Apparatus and method for capsule formation in tissue |
AU2009289484B2 (en) * | 2008-09-05 | 2014-10-23 | Cardiopolymers, Inc | Apparatus and method for capsule formation in tissue |
US8187333B2 (en) * | 2008-09-18 | 2012-05-29 | Mayer Peter L | Intervertebral disc prosthesis and method for implanting and explanting |
US8814937B2 (en) | 2008-09-18 | 2014-08-26 | Peter L. Mayer | Intervertebral disc prosthesis, method for assembling, method for implanting prosthesis, and method for explanting |
US8748508B2 (en) * | 2008-12-29 | 2014-06-10 | DePuy Synthes Products, LLC | Method of forming and the resulting membrane composition for surgical site preservation |
US8636803B2 (en) | 2009-04-07 | 2014-01-28 | Spinal Stabilization Technologies, Llc | Percutaneous implantable nuclear prosthesis |
US8394125B2 (en) * | 2009-07-24 | 2013-03-12 | Zyga Technology, Inc. | Systems and methods for facet joint treatment |
US20120209329A1 (en) * | 2011-02-11 | 2012-08-16 | Terumo Kabushiki Kaisha | Method for dilating between spinous processes |
CA3048443C (en) | 2011-05-26 | 2021-01-05 | Cartiva, Inc. | Tapered joint implant and related tools |
US9393126B2 (en) | 2012-04-20 | 2016-07-19 | Peter L. Mayer | Bilaterally placed disc prosthesis for spinal implant and method of bilateral placement |
US9364339B2 (en) | 2012-04-30 | 2016-06-14 | Peter L. Mayer | Unilaterally placed expansile spinal prosthesis |
US9095443B2 (en) | 2012-05-08 | 2015-08-04 | Eric R. VonGunten | Nucleus pulposus spinal implant and method of using the same |
USD732667S1 (en) | 2012-10-23 | 2015-06-23 | Providence Medical Technology, Inc. | Cage spinal implant |
USD745156S1 (en) | 2012-10-23 | 2015-12-08 | Providence Medical Technology, Inc. | Spinal implant |
EP2938297A4 (en) * | 2012-12-26 | 2016-09-21 | Scott A Koss | Apparatus, kit, and method for percutaneous intervertebral disc restoration |
US9192420B2 (en) | 2013-01-24 | 2015-11-24 | Kyphon Sarl | Surgical system and methods of use |
US20140277467A1 (en) | 2013-03-14 | 2014-09-18 | Spinal Stabilization Technologies, Llc | Prosthetic Spinal Disk Nucleus |
US9295479B2 (en) | 2013-03-14 | 2016-03-29 | Spinal Stabilization Technologies, Llc | Surgical device |
US9731122B2 (en) | 2013-04-29 | 2017-08-15 | Rainbow Medical Ltd. | Electroosmotic tissue treatment |
RU2561120C1 (en) * | 2014-03-13 | 2015-08-20 | Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) | Method of forming polyvinyl alcohol cryogels |
US9610150B2 (en) * | 2014-03-18 | 2017-04-04 | Boston Scientific Scimed, Inc. | Devices for sizing a cavity to fit an organ and related methods of use |
JP2017516627A (en) | 2014-05-27 | 2017-06-22 | プロビデンス メディカル テクノロジー インコーポレイテッド | Lateral mass fixation implant |
US10201375B2 (en) | 2014-05-28 | 2019-02-12 | Providence Medical Technology, Inc. | Lateral mass fixation system |
US9873769B2 (en) | 2014-07-10 | 2018-01-23 | Cambridge Polymer Group, Inc. | Thiolated PEG-PVA hydrogels |
US10786360B2 (en) | 2014-11-04 | 2020-09-29 | Spinal Stabilization Technologies Llc | Percutaneous implantable nuclear prosthesis |
EP3215067B1 (en) | 2014-11-04 | 2020-06-10 | Spinal Stabilization Technologies LLC | Percutaneous implantable nuclear prosthesis |
AU2016243659B2 (en) | 2015-03-31 | 2020-04-23 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
AU2016243660B2 (en) | 2015-03-31 | 2020-11-12 | Cartiva, Inc. | Carpometacarpal (CMC) implants and methods |
WO2016168363A1 (en) | 2015-04-14 | 2016-10-20 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
US9616221B2 (en) | 2015-07-08 | 2017-04-11 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
JP6891176B2 (en) | 2015-09-01 | 2021-06-18 | スパイナル スタビライゼーション テクノロジーズ リミテッド ライアビリティ カンパニー | Implantable nucleus pulposus prosthesis |
USD841165S1 (en) | 2015-10-13 | 2019-02-19 | Providence Medical Technology, Inc. | Cervical cage |
WO2017066475A1 (en) | 2015-10-13 | 2017-04-20 | Providence Medical Technology, Inc. | Spinal joint implant delivery device and system |
US10898716B2 (en) | 2015-10-29 | 2021-01-26 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
US9724515B2 (en) | 2015-10-29 | 2017-08-08 | Rainbow Medical Ltd. | Electrical substance clearance from the brain for treatment of Alzheimer's disease |
US10518085B2 (en) | 2015-12-29 | 2019-12-31 | Rainbow Medical Ltd. | Disc therapy |
US11484706B2 (en) | 2015-12-29 | 2022-11-01 | Discure Technologies Ltd | Disc therapy |
US9770591B2 (en) | 2015-12-29 | 2017-09-26 | Rainbow Medical Ltd. | Disc therapy |
US9950156B2 (en) | 2016-09-13 | 2018-04-24 | Rainbow Medical Ltd. | Disc therapy |
US11179493B2 (en) | 2016-04-07 | 2021-11-23 | Rowan University | Methods and compositions for inducing multi-targeted healing of intervertebral disc defects |
CN109640891A (en) | 2016-06-28 | 2019-04-16 | 普罗维登斯医疗技术公司 | Spinal implant and its application method |
USD887552S1 (en) | 2016-07-01 | 2020-06-16 | Providence Medical Technology, Inc. | Cervical cage |
CN108211067B (en) * | 2016-12-22 | 2020-11-17 | 宜鑫兴业有限公司 | Airway device |
US10569086B2 (en) | 2017-01-11 | 2020-02-25 | Rainbow Medical Ltd. | Electrical microglial cell activation |
US10758722B2 (en) | 2017-05-03 | 2020-09-01 | Rainbow Medical Ltd. | Electrical treatment of Parkinson's disease |
CN110891501A (en) | 2017-05-19 | 2020-03-17 | 普罗维登斯医疗技术公司 | Spinal fixation access and delivery system |
WO2019136263A1 (en) | 2018-01-04 | 2019-07-11 | Providence Medical Technology, Inc. | Facet screw and delivery device |
US11419733B2 (en) | 2018-01-12 | 2022-08-23 | Percheron Spine, Llc | Spinal disc implant and device and method for percutaneous delivery of the spinal disc implant |
EP3765141A1 (en) | 2018-03-14 | 2021-01-20 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
US11744710B2 (en) | 2018-09-04 | 2023-09-05 | Spinal Stabilization Technologies Llc | Implantable nuclear prosthesis, kits, and related methods |
USD933230S1 (en) | 2019-04-15 | 2021-10-12 | Providence Medical Technology, Inc. | Cervical cage |
USD911525S1 (en) | 2019-06-21 | 2021-02-23 | Providence Medical Technology, Inc. | Spinal cage |
US11123197B2 (en) * | 2019-09-03 | 2021-09-21 | Rainbow Medical Ltd. | Hydropneumatic artificial intervertebral disc |
EP3791831A1 (en) | 2019-09-10 | 2021-03-17 | AIT Austrian Institute of Technology GmbH | Implant for treatment of a hernia |
US10881858B1 (en) | 2019-09-18 | 2021-01-05 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
USD945621S1 (en) | 2020-02-27 | 2022-03-08 | Providence Medical Technology, Inc. | Spinal cage |
US11298530B1 (en) | 2021-05-03 | 2022-04-12 | Discure Technologies Ltd. | Synergistic therapies for intervertebral disc degeneration |
US11344721B1 (en) | 2021-08-16 | 2022-05-31 | Rainbow Medical Ltd. | Cartilage treatment |
US11413455B1 (en) | 2022-02-08 | 2022-08-16 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047055A (en) * | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
US5192326A (en) * | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5531028A (en) * | 1994-11-16 | 1996-07-02 | Flippen; James | Printed sheet measuring device |
US5863551A (en) * | 1996-10-16 | 1999-01-26 | Organogel Canada Ltee | Implantable polymer hydrogel for therapeutic uses |
US5976186A (en) * | 1994-09-08 | 1999-11-02 | Stryker Technologies Corporation | Hydrogel intervertebral disc nucleus |
US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
WO2001032100A2 (en) * | 1999-10-29 | 2001-05-10 | Drexel University | Associating hydrogels for nucleus pulposus replacement in intervertebral discs |
US20030033017A1 (en) * | 2001-06-29 | 2003-02-13 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
US20030134032A1 (en) * | 2001-11-16 | 2003-07-17 | Hassan Chaouk | Methods for initiating in situ formation of hydrogels |
US20040029994A1 (en) * | 2000-03-15 | 2004-02-12 | Yu-Ling Cheng | Thermally reversible implant and filler |
US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US20040091540A1 (en) * | 2000-11-15 | 2004-05-13 | Desrosiers Eric Andre | Method for restoring a damaged or degenerated intervertebral disc |
US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
US6830670B1 (en) * | 1998-12-30 | 2004-12-14 | Institut Curie | Heat-sensitive medium for separating species in a separating channel and use thereof |
US20050055099A1 (en) * | 2003-09-09 | 2005-03-10 | Ku David N. | Flexible spinal disc |
US6932843B2 (en) * | 2002-09-25 | 2005-08-23 | Medicinelodge, Inc. | Apparatus and method for the in-situ formation of a structural prosthesis |
US20060009844A1 (en) * | 2004-06-18 | 2006-01-12 | Aesculap Ag & Co. Kg | Implant |
US20060177468A1 (en) * | 2005-01-05 | 2006-08-10 | Philadelphia Health and Education Corporation (d/b/a Drexel University College of Medicine | Delivery vehicles, bioactive substances and viral vaccines |
US20060206209A1 (en) * | 2003-10-23 | 2006-09-14 | Cragg Andrew H | Prosthetic nucleus apparatus and methods |
US20060241768A1 (en) * | 2005-04-25 | 2006-10-26 | Sdgi Holdings, Inc. | Selectively expandable composite structures for spinal arthroplasty |
US20060293561A1 (en) * | 2005-06-24 | 2006-12-28 | Abay Eustaquio O Ii | System and methods for intervertebral disc surgery |
US20070073402A1 (en) * | 2005-08-26 | 2007-03-29 | Edward Vresilovic | Hydrogel balloon prosthesis for nucleus pulposus |
US7214245B1 (en) * | 1999-10-29 | 2007-05-08 | Drexel University | Associating hydrogels for nucleus pulposus replacement in intervertebral discs |
US7850730B2 (en) * | 2005-03-29 | 2010-12-14 | Synthes Usa, Llc | Method and apparatus for implanting a hydrogel prosthesis for a nucleus pulposus |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260066A (en) * | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
US5534028A (en) * | 1993-04-20 | 1996-07-09 | Howmedica, Inc. | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
US5824093A (en) * | 1994-10-17 | 1998-10-20 | Raymedica, Inc. | Prosthetic spinal disc nucleus |
JP3606681B2 (en) | 1996-05-31 | 2005-01-05 | 株式会社カネカ | Catheter balloon and manufacturing method thereof |
US20020026244A1 (en) | 2000-08-30 | 2002-02-28 | Trieu Hai H. | Intervertebral disc nucleus implants and methods |
JP2004507318A (en) * | 2000-08-30 | 2004-03-11 | エスディージーアイ・ホールディングス・インコーポレーテッド | Disc nucleus pulposus implant and method |
WO2002085262A1 (en) | 2001-04-24 | 2002-10-31 | Galley Geoffrey H | Surgical restoration of an intervertebral disc |
AU2002223365B2 (en) * | 2001-12-05 | 2005-06-30 | Synthes Gmbh | Intervertebral disk prosthesis or nucleus replacement prosthesis |
DE50210179D1 (en) * | 2002-04-04 | 2007-06-28 | Synthes Gmbh | BRAKE PURTHEES OR NUCLEUS REPLACEMENT PROSTHESIS |
JP2004007318A (en) | 2002-06-03 | 2004-01-08 | Matsushita Electric Ind Co Ltd | Method for switching channel in television receiver |
US20040016648A1 (en) | 2002-07-24 | 2004-01-29 | Applied Materials, Inc. | Tilted electrochemical plating cell with constant wafer immersion angle |
EP1626799B1 (en) * | 2003-04-30 | 2010-04-14 | Drexel University | Thermogelling polymer blends for biomaterial applications |
WO2005032358A2 (en) | 2003-10-02 | 2005-04-14 | Endius, Inc. | Methods, systems and apparatuses for performing minimally invasive spinal procedures |
DE602005024815D1 (en) | 2004-05-21 | 2010-12-30 | Synthes Gmbh | REPLACEMENT OF NUCLEUS PULPOSUS WITH A HYDROGEL |
-
2006
- 2006-08-25 BR BRPI0615391-7A patent/BRPI0615391A2/en active Search and Examination
- 2006-08-25 EP EP06813765A patent/EP1917050B1/en active Active
- 2006-08-25 CN CN2006800394346A patent/CN101365500B/en not_active Expired - Fee Related
- 2006-08-25 DE DE602006013649T patent/DE602006013649D1/en active Active
- 2006-08-25 ES ES06813765T patent/ES2340526T3/en active Active
- 2006-08-25 KR KR1020087005531A patent/KR20080036217A/en not_active Application Discontinuation
- 2006-08-25 AU AU2006282883A patent/AU2006282883A1/en not_active Abandoned
- 2006-08-25 PL PL06813765T patent/PL1917050T3/en unknown
- 2006-08-25 CA CA002620239A patent/CA2620239A1/en not_active Abandoned
- 2006-08-25 WO PCT/US2006/033276 patent/WO2007025164A2/en active Application Filing
- 2006-08-25 JP JP2008528212A patent/JP4896135B2/en not_active Expired - Fee Related
- 2006-08-25 AT AT06813765T patent/ATE464076T1/en active
- 2006-08-25 US US11/510,747 patent/US8287595B2/en active Active
- 2006-08-25 NZ NZ566184A patent/NZ566184A/en unknown
- 2006-08-25 ZA ZA200802596A patent/ZA200802596B/en unknown
-
2009
- 2009-10-29 US US12/608,565 patent/US20100047437A1/en not_active Abandoned
Patent Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047055A (en) * | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
US5192326A (en) * | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5976186A (en) * | 1994-09-08 | 1999-11-02 | Stryker Technologies Corporation | Hydrogel intervertebral disc nucleus |
US6280475B1 (en) * | 1994-09-08 | 2001-08-28 | Stryker Technologies Corporation | Hydrogel intervertebral disc nucleus implantation method |
US5531028A (en) * | 1994-11-16 | 1996-07-02 | Flippen; James | Printed sheet measuring device |
US5863551A (en) * | 1996-10-16 | 1999-01-26 | Organogel Canada Ltee | Implantable polymer hydrogel for therapeutic uses |
US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
US6830670B1 (en) * | 1998-12-30 | 2004-12-14 | Institut Curie | Heat-sensitive medium for separating species in a separating channel and use thereof |
WO2001032100A2 (en) * | 1999-10-29 | 2001-05-10 | Drexel University | Associating hydrogels for nucleus pulposus replacement in intervertebral discs |
US7214245B1 (en) * | 1999-10-29 | 2007-05-08 | Drexel University | Associating hydrogels for nucleus pulposus replacement in intervertebral discs |
US20040029994A1 (en) * | 2000-03-15 | 2004-02-12 | Yu-Ling Cheng | Thermally reversible implant and filler |
US20040091540A1 (en) * | 2000-11-15 | 2004-05-13 | Desrosiers Eric Andre | Method for restoring a damaged or degenerated intervertebral disc |
US20030033017A1 (en) * | 2001-06-29 | 2003-02-13 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
US20030134032A1 (en) * | 2001-11-16 | 2003-07-17 | Hassan Chaouk | Methods for initiating in situ formation of hydrogels |
US6932843B2 (en) * | 2002-09-25 | 2005-08-23 | Medicinelodge, Inc. | Apparatus and method for the in-situ formation of a structural prosthesis |
US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
US20050055099A1 (en) * | 2003-09-09 | 2005-03-10 | Ku David N. | Flexible spinal disc |
US20060206209A1 (en) * | 2003-10-23 | 2006-09-14 | Cragg Andrew H | Prosthetic nucleus apparatus and methods |
US20060009844A1 (en) * | 2004-06-18 | 2006-01-12 | Aesculap Ag & Co. Kg | Implant |
US20060177468A1 (en) * | 2005-01-05 | 2006-08-10 | Philadelphia Health and Education Corporation (d/b/a Drexel University College of Medicine | Delivery vehicles, bioactive substances and viral vaccines |
US7850730B2 (en) * | 2005-03-29 | 2010-12-14 | Synthes Usa, Llc | Method and apparatus for implanting a hydrogel prosthesis for a nucleus pulposus |
US20060241768A1 (en) * | 2005-04-25 | 2006-10-26 | Sdgi Holdings, Inc. | Selectively expandable composite structures for spinal arthroplasty |
US20060293561A1 (en) * | 2005-06-24 | 2006-12-28 | Abay Eustaquio O Ii | System and methods for intervertebral disc surgery |
US20070073402A1 (en) * | 2005-08-26 | 2007-03-29 | Edward Vresilovic | Hydrogel balloon prosthesis for nucleus pulposus |
US8287595B2 (en) * | 2005-08-26 | 2012-10-16 | Synthes Usa, Llc | Hydrogel balloon prosthesis for nucleus pulposus |
Non-Patent Citations (1)
Title |
---|
Hassan et al., "Cellular PVA Hydrogels Produced by Freeze/Thawing", Journal of Applied Polymer Science, 76, pp. 2075-2079, 2000. * |
Also Published As
Publication number | Publication date |
---|---|
WO2007025164A3 (en) | 2007-12-06 |
ES2340526T3 (en) | 2010-06-04 |
US8287595B2 (en) | 2012-10-16 |
EP1917050A2 (en) | 2008-05-07 |
CN101365500B (en) | 2013-01-16 |
BRPI0615391A2 (en) | 2011-05-17 |
AU2006282883A1 (en) | 2007-03-01 |
DE602006013649D1 (en) | 2010-05-27 |
CA2620239A1 (en) | 2007-03-01 |
US20070073402A1 (en) | 2007-03-29 |
JP4896135B2 (en) | 2012-03-14 |
ZA200802596B (en) | 2009-03-25 |
CN101365500A (en) | 2009-02-11 |
ATE464076T1 (en) | 2010-04-15 |
EP1917050B1 (en) | 2010-04-14 |
NZ566184A (en) | 2010-07-30 |
PL1917050T3 (en) | 2010-08-31 |
KR20080036217A (en) | 2008-04-25 |
JP2009505750A (en) | 2009-02-12 |
WO2007025164A2 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8287595B2 (en) | Hydrogel balloon prosthesis for nucleus pulposus | |
US11045324B2 (en) | Method of implanting a curable implant material | |
US7156877B2 (en) | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs | |
US8118874B2 (en) | Replacement or supplementation of a nucleus pulposus using a hydrogel | |
US20090112221A1 (en) | System and method for measuring the shape of internal body cavities | |
US20060149380A1 (en) | Systems, devices and methods for treatment of intervertebral disorders | |
US20090234457A1 (en) | Systems, devices and methods for treatment of intervertebral disorders | |
EP2285312A1 (en) | Systems methods and apparatuses for formation and insertion of tissue prostheses | |
EP2641566A1 (en) | Fillable prosthetic implant with gel-like properties | |
WO2007133214A1 (en) | Prosthetic disc nuclear replacement and soft-tissue reconstruction devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |